Pharmeasy Limited Unlisted Shares (PharmEasy)

-22.72 % 1 M

About Pharmeasy Limited Unlisted Shares (PharmEasy)

A Comprehensive Overview of Price & Journey
Understanding Pharmeasy Limited Unlisted Shares (PharmEasy) Inception and Growth
SHOW MORE...

About Pharmeasy Limited Unlisted Shares (PharmEasy)

IPO Details, Price movement

PharmEasy Board of Directors

Vineet Rai Independent Director
Subramaniam Somasundaram Independent Director
Jaydeep Dahyalal Tank Independent Director
Aditya Puri Professional Director
Deepak Calian Vaidya Independent Director
Ankur Nand Thadani Professional Director
Ashutosh Sharma Professional Director
Siddharth Bhaskar Shah Managing Director
Dhaval Shah Whole-Time Director
Dovaldas Buzinskas Professional Director
Hardik Kishor Dedhia Whole-Time Director
Ranjan Ramdas Pai Professional Director
Shyam Powar Professional Director

PharmEasy Unlisted Share Price

The PharmEasy unlisted share price is updated regularly on our website. Investors looking to track the latest market activity, valuation changes, and transaction trends can visit our platform for all the latest updates.

Why Investors Are Interested in PharmEasy Share

PharmEasy has become one of India's most recognized health-tech companies by combining healthcare services and technology on a single platform. Several factors continue to drive investor interest in PharmEasy Share:

  • Strong brand recognition in India's digital healthcare market.
  • Presence across online pharmacies and diagnostics as well as telehealth services.
  • Large and growing healthcare market opportunity.
  • Increasing adoption of digital healthcare solutions across India.
  • Potential long-term value creation through a future PharmEasy IPO.
  • Opportunity for investors to gain exposure through PharmEasy Unlisted Share Price before a public listing.

Company Overview

India's healthcare industry is undergoing a digital transformation, and PharmEasy is one of the key players leading the change. The company's technology platform is designed to increase the accessibility, affordability, and convenience for consumers in the healthcare industry.

PharmEasy's services go beyond medicine delivery. It also lets users book lab tests, access healthcare consultations, and buy health care products, making for a full healthcare experience under a single brand.

As one of the largest players in India's online healthcare ecosystem, the company is well positioned to benefit from increasing healthcare spending and the growing shift toward digital services.

Industry Outlook

India's healthcare industry offers significant long-term growth opportunities, with digital healthcare emerging as one of the fastest-growing segments. Rising internet penetration, increasing healthcare awareness, and changing consumer preferences are accelerating the adoption of online healthcare services.

Online pharmacies are a significant part of the healthcare ecosystem, especially since the pandemic sparked a greater shift toward digital healthcare options. The ease of ordering medicines online, booking diagnostic tests from home, and consulting doctors remotely has resulted in great demand across the sector.

Despite the expansion, digital healthcare penetration in India is still lower than in developed countries, with significant potential for expansion still to be realized. This offers a favorable opportunity for companies such as PharmEasy that are focused on building scalable healthcare platforms.

As digital healthcare adoption continues to increase, PharmEasy is expected to remain a key player in the sector, supported by its strong customer base, diversified service offerings, and established market presence as well.

SHOW MORE...

Fundamentals

Market Cap (in cr.)
₹ 0
P/E Ratio
0.00
P/B Ratio
2.11
Debt to Equity
0.00
ROE (%)
222.49
Book Value
4.03
Face Value
1.00
Total Shares
0
Category
Unlisted Shares
Unlisted CMP
₹ 0 / Share
Lot Size
0 Shares
52 Week High
₹0.00
52 Week Low
₹0.00
Depository
NSDL & CDSL
PAN Number
AASCA1201E
ISIN Number
INE0DJ201029
CIN
U60100MH2019PLC323444
Sector
Health Care

Financials

All values are INR Cr except per share value

P&L Statement 2022 2023 2024
Revenue 5728.82 6643.94 5664.29
Other Income 52.18 55.83 94.66
COGS 85.46 156.92 164.51
Gross Profit 5695.54 6542.85 5594.43
Total Expense 8247.35 8573.32 699.36
EBIDTA -2551.81 -2030.80 -1279.91
D&A 158.79 243.44 215.95
EBIT -2710.59 -2274.24 -1495.86
PBT -3983.95 -5196.22 -2522.85
TAX 21.73 15.21 11.54
PAT -4005.67 -5196.22 -2522.85
Diluted EPS -7.28 -8.51 -4.07
Basic EPS -7.28 -8.51 -4.07
Total income 5,781.00 6,699.77 5,758.95
ASSETS
CURRENT ASSETS 2022 2023 2024
Cash and Cash Equivalents 154.40 193.65 327.99
Trade Payables 860.85 905.03 706.21
Inventory 761.24 688.16 555.56
Other Current Assets 725.72 748.02 1886.49
Total Current Assets 2,502.21 2,534.86 3,476.25

NON CURRENT ASSETS 2022 2023 2024
Plant Property and Equipment 361.38 337.90 286.24
Other Non Current Assets 8534.74 5383.65 4627.17
Total Non Current Assets 8,896.12 5,721.55 4,913.41

Total Assets 11,398.33 8,256.41 8,389.66

CURRENT LIABILITES 2022 2023 2024
TRADW Payable 458.88 413.41 412.91
Other Current Liab 3302.73 1909.81 3089.57

NON CURRENTLIABILITIES 2022 2023 2024
Long Term Debt 100.07 - -
Deffered Tax Liab 196.76 179.37 173.27
Other Non Current Liab 317.41 3316.93 2125.60

LIABILITIES
EQUITY 2022 2023 2024
Share Capital 614.20 614.20 624.04
Other Equity 6408.28 1822.69 1964.27
Total Equity 7,022.48 2,436.89 2,588.31

Total Liabilities & Equity 7,022.48 2,436.89 2,588.31

CASH FLOW STAT 2022 2023 2024
Cash Flow from operating - -2589.37 -746.59 -61.14
Cash Flow from financing - 8305.37 853.49 1456.83
Cash Flow from investing - -5789.21 -71.08 -1260.95
Net cash flow 0.00 -73.21 35.82 134.74

Revenue Growth
PAT Growth %
EPS Growth %
TOTAL ASSETS Growth %
QUICK RATIO Growth %
LONG TERM DEBT TO EQUITY RATIO Growth %
Shareholding Pattern
2026
Name Designation Share %
Naspers Ventures B.V. NA 13.03%
MacRitchie Investment Pte. Ltd. NA 11.74%
TPG Growth V SF Markets Pte. Ltd NA 7.20%
Evermed Holdings Pte. Ltd NA 6.35%
Prasid Uno Family Trust Through Its Trustee Surbhi Singh NA 4.39%
Others NA 57.29%
Events
Name Date Details
No events available.
Promoters or Management
Name Designation Linkedin Profile
Dr.Dhaval shah Co-Founder, CBO
Siddharth Shah COE
Abhinav Jain Ranka CFO

Frequently Asked Questions

1. How is the price of an unlisted share of Pharmeasy Limited determined?

Like any other financial product or commodity, the price of unlisted shares is discovered at the intersection of demand from buyers and supply from sellers of particular unlisted shares.

The two determinants of price are dynamic factors and keep changing constantly, hence share price tends to fluctuate constantly – every day, every minute.

2. How shares of Pharmeasy Limited are delivered and held?
3. What is the lock-in period of Pharmeasy Limited ?
4. What is the minimum ticket size required to invest in Pharmeasy Limited ?
5. How much Short-Term Capital Gain tax do I require to pay on Pharmeasy Limited ?
6. How much Long-Term Capital Gain tax do I require to pay on Pharmeasy Limited ?
7. How to check credit of Pharmeasy Limited Unlisted Shares Unlisted Shares/Pre-IPO shares?
8. How is valuation of Pharmeasy Limited Unlisted Shares Unlisted Shares/Pre-IPO shares decided?
9. Is investing in Pharmeasy Limited legal in India?
10. Is investing in Pharmeasy Limited safe?

Related News